Oral Orforglipron Yields Greater Weight Reductions Than Placebo

THURSDAY, Sept. 25, 2025 -- For adults with obesity who do not have diabetes, the oral glucagon-like peptide-1 receptor agonist orforglipron yields significantly greater reductions in body weight than placebo, according to a study published online...